ReviewRSC advances2025
Heterogeneous organocatalysis: the proline case.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asymmetric catalysis has allowed organic chemists to synthesize chiral molecules, such as amino acids, nucleic acids, sugars, and drugs. To achieve this, it is common to use a chiral catalyst to selectively accelerate the reaction. In the early days, it was believed that there were two main types of effective asymmetric catalysts: enzyme complexes and transition metal complexes. However, with the emergence of organocatalysis and the consequent introduction of a new category of highly effective asymmetric catalysts based solely on organic compounds, there was a revolution in the field of asymmetric catalysis. An excellent example of this innovation is l-proline, a fascinating molecule that demonstrates the transformative impact of organocatalysis. Organocatalysis presents itself as a simpler synthetic tool than other methodologies, however, despite being widely used in the research environment, it has not yet reached large-scale production. This gap occurs mainly due to the methodology working in a homogeneous phase together with the rest of the reagents involved. Although this does not present a problem on a laboratory scale, the recovery and reuse of the catalyst can be an obstacle in industrial processes. In recent years, with a view to some industrial uses, there has been an effort to make the immobilization (also called heterogenization) of organocatalysts possible. Such modified systems have broad catalytic applications in several organic transformations. Taking this into consideration, this review has the general objective of investigating the application of different supports in the immobilization of the classical organocatalyst l-proline, synthesized and characterized by three different methodologies, namely: impregnation, intercalation and grafting.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.